Home Compare ORNBV.HE vs SAN.PA
Stock Comparison · Industry comparison · Drug Manufacturers - General

Orion Oyj vs Sanofi: Which Stock Looks Stronger in 2026?

Orion Oyj holds the cleaner structural position, with the lead spread across profitability and growth. Sanofi does not offset that deficit through any equally strong structural edge elsewhere. On the market side, Orion Oyj is in better shape — its trend is intact while Sanofi's trend has broken down. That puts structure and market broadly in agreement — Orion Oyj's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in profitability, but growth adds another real layer to the result. Orion Oyj leads by 37 points on the overall comparison score.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. ORNBV.HE and SAN.PA share the same industry classification.

For a similarity-based comparison, see how Orion Oyj and Sanofi each position within their functional peer groups in AssetNext.

Peer-Relative Score
ORNBV.HE
Orion Oyj
83
Peer-Score
Signal qualityHigh
vs
SAN.PA
Sanofi
46
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: ORNBV.HE vs SAN.PA Profitability 100 16 Stability 71 67 Valuation 61 59 Growth 100 51 ORNBV.HE SAN.PA
Gap Ranking
#1 Profitability +84
#2 Growth +49
#3 Stability +4
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ORNBV.HE and SAN.PA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ORNBV.HESAN.PA Relative valuation Structural strength

The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Orion Oyj ranks near the top of the group on profitability; Sanofi sits in the weaker half.
Growth
On growth, the edge is clear — both rank well, but Orion Oyj sits noticeably higher.
Profitability — Dominant Gap
ORNBV.HE
100
SAN.PA
16
Gap+84in favour of ORNBV.HE

The profitability lead is mainly driven by a 33-point operating margin advantage.

What keeps the gap from being one-sided

Sanofi still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.

What this means for the comparison

The lead is built on both profitability and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the ORNBV.HE vs SAN.PA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-growth comparisons

Explore how ORNBV.HE and SAN.PA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.